ACCELERON PHARMA INC. Accounts Receivable
ACCELERON PHARMA INC. had Accounts Receivable of $3.02 million as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2016-11-03
- 2016-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.02M.
- 2016-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.24M.
- 2016-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.06M.
- 2015-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.63M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2016-09-30 | $3.02M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $3.24M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $3.06M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.63M 10-Q · filed 2016-11-03 |
| 2015-09-30 | $3.95M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $5.29M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $4.05M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $3.37M 10-K · filed 2016-02-25 |
| 2014-09-30 | $3.23M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $3.73M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $2.63M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $3.62M 10-K · filed 2015-03-02 |
| 2013-09-30 | $4.10M 10-Q · filed 2013-11-14 |
| 2012-12-31 | $2.78M 10-K · filed 2014-03-17 |